BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet. 2002;359:331-340. [PMID: 11830216 DOI: 10.1016/s0140-6736(02)07499-8] [Cited by in Crossref: 208] [Cited by in F6Publishing: 174] [Article Influence: 10.4] [Reference Citation Analysis]
Number Citing Articles
1 Xing H, Zhang Y, Krämer M, Kissmann A, Amann V, Raber HF, Weil T, Stieger KR, Knippschild U, Henkel M, Andersson J, Rosenau F. A Polyclonal Aptamer Library for the Specific Binding of the Gut Bacterium Roseburia intestinalis in Mixtures with Other Gut Microbiome Bacteria and Human Stool Samples. IJMS 2022;23:7744. [DOI: 10.3390/ijms23147744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alugoju P, Krishna Swamy VKD, Anthikapalli NVA, Tencomnao T. Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. Crit Rev Food Sci Nutr 2022;:1-66. [PMID: 35708049 DOI: 10.1080/10408398.2022.2084600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kushkevych I, Jampílek J. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00016-7] [Reference Citation Analysis]
4 Rao J, Shao L, Lin M, Huang J, Fan L. LncRNA UCA1 Accelerates the Progression of Ulcerative Colitis via Mediating the miR-331-3p/BRD4 Axis. Int J Gen Med 2021;14:2427-35. [PMID: 34140798 DOI: 10.2147/IJGM.S304837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sheng Q, Li F, Chen G, Li J, Li J, Wang Y, Lu Y, Li Q, Li M, Chai K. Ursolic Acid Regulates Intestinal Microbiota and Inflammatory Cell Infiltration to Prevent Ulcerative Colitis. J Immunol Res 2021;2021:6679316. [PMID: 34007853 DOI: 10.1155/2021/6679316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Metwally DM, Al-Otaibi TT, Semlali A, Alajmi RA. Sarcocystis camelicanis increases interleukin (IL)-6 expression in one-humped camels (Camelus dromedarius) from Riyadh and Al Qassim, Saudi Arabia. Biosci Rep 2021;41:BSR20203140. [PMID: 33409539 DOI: 10.1042/BSR20203140] [Reference Citation Analysis]
7 Pei LY, Ke YS, Zhao HH, Liu WZ, Wang L, Jia C, Shi MN, Fu QH, Cui J, Li SC. Regulatory effect of Garidisan on dysbiosis of the gut microbiota in the mouse model of ulcerative colitis induced by dextran sulfate sodium. BMC Complement Altern Med 2019;19:329. [PMID: 31752807 DOI: 10.1186/s12906-019-2750-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Sun W, Han H, Wang Z, Wen Z, Yang M, Wang Y, Fu J, Feng L, Xu X, Yin T, Wang X, Lu G, Qi J, Lin H, Yang Y. Natural naphthoquinones isolated from Lithospermum erythrorhizon suppress dextran sulfate sodium-induced murine experimental colitis.. [DOI: 10.1101/830224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Tas EO, Pala E, Ercan I, Sag S. Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis. Turkish Journal of Biochemistry 2019;44:411-416. [DOI: 10.1515/tjb-2018-0448] [Reference Citation Analysis]
10 Pei LY, Ke YS, Zhao HH, Wang L, Jia C, Liu WZ, Fu QH, Shi MN, Cui J, Li SC. Role of colonic microbiota in the pathogenesis of ulcerative colitis. BMC Gastroenterol. 2019;19:10. [PMID: 30642266 DOI: 10.1186/s12876-019-0930-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
11 Saha S, Martin A, Navarre WW. Meta-analysis identifies microbial signatures of disease in murine models of inflammatory bowel disease.. [DOI: 10.1101/515205] [Reference Citation Analysis]
12 Lee KW, Kim M, Lee CH. Treatment of Dextran Sulfate Sodium-Induced Colitis with Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor MI-2 Is Associated with Restoration of Gut Immune Function and the Microbiota. Infect Immun 2018;86:e00091-18. [PMID: 30249750 DOI: 10.1128/IAI.00091-18] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
13 Xiao N, Liu F, Zhou G, Sun M, Ai F, Liu Z. Food-specific IgGs Are Highly Increased in the Sera of Patients with Inflammatory Bowel Disease and Are Clinically Relevant to the Pathogenesis. Intern Med 2018;57:2787-98. [PMID: 29780153 DOI: 10.2169/internalmedicine.9377-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Chen G, Ran X, Li B, Li Y, He D, Huang B, Fu S, Liu J, Wang W. Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model. EBioMedicine. 2018;30:317-325. [PMID: 29627390 DOI: 10.1016/j.ebiom.2018.03.030] [Cited by in Crossref: 163] [Cited by in F6Publishing: 178] [Article Influence: 40.8] [Reference Citation Analysis]
15 Liu W, Guo W, Hang N, Yang Y, Wu X, Shen Y, Cao J, Sun Y, Xu Q. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation. Oncotarget 2016;7:30536-49. [PMID: 27105502 DOI: 10.18632/oncotarget.8867] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
16 Stawowczyk E, Kawalec P. Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review. Prz Gastroenterol 2017;12:90-7. [PMID: 28702096 DOI: 10.5114/pg.2017.68166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Wada K, Usuda H. Therapeutic strategies for intractable digestive diseases: importance of disease models for evaluation of drug efficacy. Folia Pharmacol Jpn 2017;150:183-187. [DOI: 10.1254/fpj.150.183] [Reference Citation Analysis]
18 Kim TK, Park YS, Baik HW, Jun JH, Kim EK, Sull JW, Sung HJ, Choi JW, Chung SH, Gye MC, Lim JY, Kim JB, Kim SH. Melatonin modulates adiponectin expression on murine colitis with sleep deprivation. World J Gastroenterol 2016; 22(33): 7559-7568 [PMID: 27672276 DOI: 10.3748/wjg.v22.i33.7559] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Zhang Y, Wang Z, Liu J, Zhang S, Fei J, Li J, Zhang T, Wang J, Park PW, Chen Y. Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis. J Cell Mol Med 2017;21:13-25. [PMID: 27558380 DOI: 10.1111/jcmm.12934] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
20 Stawowczyk E, Kawalec P, Pilc A. Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland. Eur J Clin Pharmacol 2016;72:1319-25. [PMID: 27497991 DOI: 10.1007/s00228-016-2103-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Stawowczyk E, Kawalec P, Pilc A. Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland. PLoS One 2016;11:e0160444. [PMID: 27494322 DOI: 10.1371/journal.pone.0160444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tian T, Zhou Y, Feng X, Ye S, Wang H, Wu W, Tan W, Yu C, Hu J, Zheng R, Chen Z, Pei X, Luo H. MicroRNA-16 is putatively involved in the NF-κB pathway regulation in ulcerative colitis through adenosine A2a receptor (A2aAR) mRNA targeting. Sci Rep 2016;6:30824. [PMID: 27476546 DOI: 10.1038/srep30824] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
23 Dou X, Xiao J, Jin Z, Zheng P. Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia. Oncol Lett 2015;10:1259-66. [PMID: 26622660 DOI: 10.3892/ol.2015.3397] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
24 Guo W, Sun Y, Liu W, Wu X, Guo L, Cai P, Wu X, Wu X, Shen Y, Shu Y, Gu Y, Xu Q. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy 2014;10:972-85. [PMID: 24879148 DOI: 10.4161/auto.28374] [Cited by in Crossref: 178] [Cited by in F6Publishing: 184] [Article Influence: 25.4] [Reference Citation Analysis]
25 Ming Z, Jia Y, Yan Y, Pang G, Chen Q. Amelioration effect of bovine casein glycomacropeptide on ulcerative colitis in mice. Food and Agricultural Immunology 2015;26:717-28. [DOI: 10.1080/09540105.2015.1018874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
26 Park YS, Chung SH, Lee SK, Kim JH, Kim JB, Kim TK, Kim DS, Baik HW. Melatonin improves experimental colitis with sleep deprivation. Int J Mol Med. 2015;35:979-986. [PMID: 25625560 DOI: 10.3892/ijmm.2015.2080] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
27 Keeley BR, Islami F, Pourshams A, Poustchi H, Pak JS, Brennan P, Khademi H, Genden EM, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R, Sikora AG. Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer. Cancer Sci 2014;105:1205-11. [PMID: 25040886 DOI: 10.1111/cas.12485] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
28 Gok I, Ucar F, Ozgur O, Celebi A, Sentã¼rk O, Hulagu S. CARD15 Gene 3020insC Mutation with Inflammatory Bowel Diseases Patients in the Black Sea Region of Turkey. Open Access Maced J Med Sci 2014;2:215-218. [DOI: 10.3889/oamjms.2014.033] [Reference Citation Analysis]
29 Macfarlane GT, Macfarlane S. Evolution of the Normal Intestinal Microbiota and Its Pathogenic Implications. Evolutionary Biology of Bacterial and Fungal Pathogens 2014. [DOI: 10.1128/9781555815639.ch8] [Reference Citation Analysis]
30 Li J, Chen C, Cao XN, Wang GH, Hu JB, Wang J. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. J Huazhong Univ Sci Technolog Med Sci 2014;34:59-65. [PMID: 24496680 DOI: 10.1007/s11596-014-1232-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
31 Li TT, Zhang JF, Fei SJ, Zhu SP, Zhu JZ, Qiao X, Liu ZB. Glutamate microinjection into the hypothalamic paraventricular nucleus attenuates ulcerative colitis in rats. Acta Pharmacol Sin 2014;35:185-94. [PMID: 24362327 DOI: 10.1038/aps.2013.140] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
32 Brazil JC, Louis NA, Parkos CA. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1556-65. [PMID: 23598816 DOI: 10.1097/MIB.0b013e318281f54e] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 10.8] [Reference Citation Analysis]
33 Chung SH, Park YS, Kim OS, Kim JH, Baik HW, Hong YO, Kim SS, Shin JH, Jun JH, Jo Y. Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis. Dig Dis Sci. 2014;59:1134-1141. [PMID: 24429513 DOI: 10.1007/s10620-013-3013-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
34 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8:e64216. [PMID: 23717571 DOI: 10.1371/journal.pone.0064216] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
35 Herbal approaches to pathological states. Principles and Practice of Phytotherapy 2013. [DOI: 10.1016/b978-0-443-06992-5.00008-6] [Reference Citation Analysis]
36 Calder P. Omega-6 and Omega-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Diseases. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease 2013. [DOI: 10.1016/b978-0-12-397154-8.00014-2] [Reference Citation Analysis]
37 Shanahan F. Ulcerative Colitis. Textbook of Clinical Gastroenterology and Hepatology 2012. [DOI: 10.1002/9781118321386.ch49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Yasuda H, Tanaka K, Okita Y, Araki T, Saigusa S, Toiyama Y, Yokoe T, Yoshiyama S, Kawamoto A, Inoue Y. CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer. Oncol Lett. 2011;2:1065-1071. [PMID: 22848268 DOI: 10.3892/ol.2011.415] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
39 Bourke B, Fleming P, Healy C. Crohn Disease and Orofacial Granulomatosis. Harper's Textbook of Pediatric Dermatology 2011. [DOI: 10.1002/9781444345384.ch157] [Reference Citation Analysis]
40 Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer. 2011;128:1999-2009. [PMID: 21387284 DOI: 10.1002/ijc.25815] [Cited by in Crossref: 193] [Cited by in F6Publishing: 206] [Article Influence: 17.5] [Reference Citation Analysis]
41 Dedon PC. Oxidation and Deamination of DNA by Endogenous Sources. Chemical Carcinogenesis 2011. [DOI: 10.1007/978-1-61737-995-6_10] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Onishi K, Munemoto Y, Takashima Y, Mitsui T, Kobayashi H, Iida Y. A CASE OF COLITIC CANCER WITH A STENOTIC LESION DEVELOPED DURING CANCER SURVEILLANCE OF ULCERATIVE COLITIS. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 2011;72:1218-1223. [DOI: 10.3919/jjsa.72.1218] [Reference Citation Analysis]
43 Braun J, Kasperk R, Saklak M, Ulmer F, Willis S. Gutartige Erkrankungen von Dickdarm und Rektum. Praxis der Viszeralchirurgie. Gastroenterologische Chirurgie 2011. [DOI: 10.1007/978-3-642-14223-9_33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Chin MP, Schauer DB, Deen WM. Nitric oxide, oxygen, and superoxide formation and consumption in macrophages and colonic epithelial cells. Chem Res Toxicol 2010;23:778-87. [PMID: 20201482 DOI: 10.1021/tx900415k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
45 De Mott MS, Dedon PC. Chemistry of Inflammation and DNA Damage: Biological Impact of Reactive Nitrogen Species. The Chemical Biology of DNA Damage 2010. [DOI: 10.1002/9783527630110.ch2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Seo GS, Lee JK, Yu JI, Yun KJ, Chae SC, Choi SC. Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis. Exp Mol Med 2010;42:99-104. [PMID: 19946179 DOI: 10.3858/emm.2010.42.2.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
47 Huda-Faujan N, Abdulamir AS, Fatimah AB, Anas OM, Shuhaimi M, Yazid AM, Loong YY. The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J. 2010;4:53-58. [PMID: 20563285 DOI: 10.2174/1874091x01004010053] [Cited by in Crossref: 210] [Cited by in F6Publishing: 216] [Article Influence: 17.5] [Reference Citation Analysis]
48 Marks DJ, Rahman FZ, Sewell GW, Segal AW. Crohn’s disease: an immune deficiency state. Clin Rev Allergy Immunol. 2010;38:20-31. [PMID: 19437144 DOI: 10.1007/s12016-009-8133-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 6.0] [Reference Citation Analysis]
49 Rahman FZ, Smith AM, Hayee B, Marks DJ, Bloom SL, Segal AW. Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4. PLoS One 2010;5:e9891. [PMID: 20360984 DOI: 10.1371/journal.pone.0009891] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
50 Kinugasa T, Akagi Y, Murotani K, Ushijima M, Shiratsuchi I, Yoshida T, Ryu Y, Shirouzu K. Statistical Analysis of The Risk Factor of Colitic Cancer in UC Patients using Tree Model. Journal of Japan Society of Coloproctology 2010;63:407-414. [DOI: 10.3862/jcoloproctology.63.407] [Reference Citation Analysis]
51 Ryu K, Huh K. Irritable Bowel Syndrome in Inflammatory Bowel Disease. Intest Res 2010;8:95. [DOI: 10.5217/ir.2010.8.2.95] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Peterson MA. Disorders of the Large Intestine. Rosen's Emergency Medicine – Concepts and Clinical Practice 2010. [DOI: 10.1016/b978-0-323-05472-0.00093-1] [Reference Citation Analysis]
53 Uchimoto K, Koyama F, Fujii H, Nakagawa T, Ohtsuki K, Nakamura S, Ueda T, Enomoto Y, Nonomura A, Nakajima Y. Sigmoidectomy for radiation-induced sigmoid colonic dysplasia 35 years after radiotherapy for cervical cancer. Clin J Gastroenterol 2009;2:412-6. [PMID: 26192797 DOI: 10.1007/s12328-009-0120-x] [Reference Citation Analysis]
54 Asano K, Matsushita T, Umeno J, Hosono N, Takahashi A, Kawaguchi T, Matsumoto T, Matsui T, Kakuta Y, Kinouchi Y, Shimosegawa T, Hosokawa M, Arimura Y, Shinomura Y, Kiyohara Y, Tsunoda T, Kamatani N, Iida M, Nakamura Y, Kubo M. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet. 2009;41:1325-1329. [PMID: 19915573 DOI: 10.1038/ng.482] [Cited by in Crossref: 188] [Cited by in F6Publishing: 195] [Article Influence: 14.5] [Reference Citation Analysis]
55 Trzcinski R, Skretkowicz J, Dziki A, Rychlik-Sych M, Baranska M. Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease. Dig Dis Sci. 2010;55:1037-1043. [PMID: 19437119 DOI: 10.1007/s10620-009-0816-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
56 Kong SC. Probiotics and prebiotics in the management of ulcerative colitis. Food Science & Technology Bulletin: Functional Foods 2009;5:93-102. [DOI: 10.1616/1476-2137.15604] [Reference Citation Analysis]
57 Narumi Y, Isomoto H, Shiota M, Sato K, Kondo S, Machida H, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol. 2009;29:303-310. [PMID: 19160029 DOI: 10.1007/s10875-008-9272-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
58 de Vaumas C, Montravers P, Dupont H. Sindromi occlusive. EMC - Anestesia-Rianimazione 2009;14:1-13. [DOI: 10.1016/s1283-0771(09)70287-7] [Reference Citation Analysis]
59 Dhir M, Montgomery EA, Glöckner SC, Schuebel KE, Hooker CM, Herman JG, Baylin SB, Gearhart SL, Ahuja N. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg 2008;12:1745-53. [PMID: 18716850 DOI: 10.1007/s11605-008-0633-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
60 Hussein IAH, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. Inflammatory bowel disease in rats: Bacterial and chemical interaction. World J Gastroenterol 2008; 14(25): 4028-4039 [PMID: 18609687 DOI: 10.3748/wjg.14.4028] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
61 Ternhag A, Törner A, Svensson A, Ekdahl K, Giesecke J. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis. 2008;14:143-148. [PMID: 18258094 DOI: 10.3201/eid1401.070524] [Cited by in Crossref: 102] [Cited by in F6Publishing: 138] [Article Influence: 7.3] [Reference Citation Analysis]
62 Bhowmick NA. TGF-β Signaling in Fibroblastic Cells and Oncogenesis. Transforming Growth Factor-β in Cancer Therapy, Volume I 2008. [DOI: 10.1007/978-1-59745-292-2_12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 de Vaumas C, Montravers P, Dupont H. Síndromes oclusivos. EMC - Anestesia-Reanimación 2008;34:1-14. [DOI: 10.1016/s1280-4703(08)70468-7] [Reference Citation Analysis]
64 de Vaumas C, Montravers P, Dupont H. Syndromes occlusifs. EMC - Anesthésie-Réanimation 2008;5:1-13. [DOI: 10.1016/s0246-0289(08)38440-0] [Reference Citation Analysis]
65 Chung HL, Yue GGL, To KF, Su YL, Huang Y, Ko WH. Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. World J Gastroenterol 2007; 13(42): 5605-5611 [PMID: 17948935 DOI: 10.3748/wjg.v13.i42.5605] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
66 Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 2007;28:1450-9. [PMID: 17723178 DOI: 10.1111/j.1745-7254.2007.00695.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 139] [Article Influence: 8.8] [Reference Citation Analysis]
67 Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-13785. [PMID: 17699621 DOI: 10.1073/pnas.0706625104] [Cited by in Crossref: 3075] [Cited by in F6Publishing: 3227] [Article Influence: 205.0] [Reference Citation Analysis]
68 Meijer MJ, Mieremet-Ooms MA, Hogezand RAV, Lamers CB, Hommes DW, Verspaget HW. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 2007; 13(21): 2960-2966 [PMID: 17589947 DOI: 10.3748/wjg.v13.i21.2960] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 69] [Article Influence: 3.7] [Reference Citation Analysis]
69 Thompson BJ, Washington MK, Kurre U, Singh M, Rula EY, Emeson RB. Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis. Dig Dis Sci 2008;53:229-41. [PMID: 17530400 DOI: 10.1007/s10620-007-9848-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
70 Tilg H. Role of cytokines and their receptors in inflammatory bowel diseases. Falk Symposium. [DOI: 10.1007/1-4020-2912-8_9] [Reference Citation Analysis]
71 Franchimont D. Mechanisms of steroid-refractory disease. Falk Symposium. [DOI: 10.1007/1-4020-2912-8_24] [Reference Citation Analysis]
72 Geenen RWF, Hussain SM, Siersema PD, Poley J, Kuipers EJ, Krestin GP. Current status of MRI in patients with inflammatory bowel disease colitis. AR 2007. [DOI: 10.37549/ar1485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Dedon PC, Barth MC. Oxidatively Damaged DNA and Inflammation. Oxidative Damage to Nucleic Acids 2007. [DOI: 10.1007/978-0-387-72974-9_15] [Reference Citation Analysis]
74 Chapman TM, Plosker GL, Figgitt DP. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs. 2006;66:1371-1387. [PMID: 16903771 DOI: 10.2165/00003495-200666100-00006] [Cited by in Crossref: 74] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
75 Kolititis. Praxis der Viszeralchirurgie. [DOI: 10.1007/978-3-540-29042-1_59] [Reference Citation Analysis]
76 Klinge U, Rosch R, Junge K, Krones CJ, Stumpf M, Lynen-Jansen P, Mertens PR, Schumpelick V. Different matrix micro-environments in colon cancer and diverticular disease. Int J Colorectal Dis. 2007;22:515-520. [PMID: 17021746 DOI: 10.1007/s00384-006-0199-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
77 Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, Casciotti L, Maganti V, Reddy PS, Strahs A, Immermann F. Molecular classification of Crohn’s disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn. 2006;8:51-61. [PMID: 16436634 DOI: 10.2353/jmoldx.2006.050079] [Cited by in Crossref: 158] [Cited by in F6Publishing: 169] [Article Influence: 9.9] [Reference Citation Analysis]
78 Spoettl T, Paetzel C, Herfarth H, Bencherif M, Schoelmerich J, Greinwald R, Gatto GJ, Rogler G. (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa. Int J Colorectal Dis 2007;22:303-12. [PMID: 16715250 DOI: 10.1007/s00384-006-0135-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
79 Ulcerative Colitis. The Epidemiology of Alimentary Diseases. [DOI: 10.1007/1-4020-3840-2_20] [Reference Citation Analysis]
80 Maroo S, Farrell RJ. From SNPs to haplotypes: unraveling the role of MDR1 in IBD. Inflamm Bowel Dis 2006;12:74-6. [PMID: 16374263 DOI: 10.1097/01.mib.0000186492.43191.d5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Ko JKS, Lam FYL, Cheung APL. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005; 11(37): 5787-5794 [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
82 Török HP, Glas J, Beynon V, Folwaczny M, Folwaczny C. Persistent dyspeptic symptoms in long-standing ulcerative colitis. Inflamm Bowel Dis 2005;11:951-2. [PMID: 16189428 DOI: 10.1097/01.mib.0000182870.68811.16] [Reference Citation Analysis]
83 Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, Ichikawa K, Tomita S, Ohkura Y, Ono Y, Imura J, Chiba T, Fujimori T. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005;54:1287-92. [PMID: 15870230 DOI: 10.1136/gut.2004.062059] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
84 Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, Kohno S, Wen CY. Crohn’s disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol 2005; 11(31): 4833-4837 [PMID: 16097053 DOI: 10.3748/wjg.v11.i31.4833] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
85 Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, Takeshima F, Mizuta Y, Niikawa N, Murata I, Kohno S. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005; 11(27): 4188-4193 [PMID: 16015687 DOI: 10.3748/wjg.v11.i27.4188] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
86 Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol 2005; 11(16): 2371-2384 [PMID: 15832404 DOI: 10.3748/wjg.v11.i16.2371] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 155] [Article Influence: 8.1] [Reference Citation Analysis]
87 Rumi G, Tsubouchi R, Okayama M, Kato S, Mózsik G, Takeuchi K. Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci. 2004;49:1466-1472. [PMID: 15481321 DOI: 10.1023/b:ddas.0000042248.48819.ad] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 3.4] [Reference Citation Analysis]
88 Klotz U, Schwab M. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev 2005;57:267-79. [PMID: 15555742 DOI: 10.1016/j.addr.2004.08.007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 5.4] [Reference Citation Analysis]
89 Colón AL, Madrigal JL, Menchén LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig Dis Sci. 2004;49:1713-1721. [PMID: 15573932 DOI: 10.1023/b:ddas.0000043391.64073.e4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
90 Watanabe T. Ulcerative colitis that developed 8 years after human parvovirus B19 encephalopathy. Eur J Pediatr. 2004;163:341-342. [PMID: 15346923 DOI: 10.1007/s00431-004-1433-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
91 Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, Lloyd AR, Grimm MC. CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 2004;53:1287-94. [PMID: 15306587 DOI: 10.1136/gut.2003.028225] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
92 Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004;53:987-92. [PMID: 15194649 DOI: 10.1136/gut.2003.030205] [Cited by in Crossref: 433] [Cited by in F6Publishing: 480] [Article Influence: 24.1] [Reference Citation Analysis]
93 Singh H, Dhagat P. Radiological Quiz. Medical Journal Armed Forces India 2004;60:181-190. [DOI: 10.1016/s0377-1237(04)80115-1] [Reference Citation Analysis]
94 Furrie E, Macfarlane S, Cummings JH, Macfarlane GT. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 2004;53:91-8. [PMID: 14684582 DOI: 10.1136/gut.53.1.91] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 3.3] [Reference Citation Analysis]
95 Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T, Matsuda K, Muto T, Nagawa H. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: Results of a 23-year surveillance programme in the Japanese population. Br J Cancer. 2003;89:1232-1236. [PMID: 14520452 DOI: 10.1038/sj.bjc.6601247] [Cited by in Crossref: 94] [Cited by in F6Publishing: 107] [Article Influence: 4.9] [Reference Citation Analysis]
96 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1782-1786 [DOI: 10.11569/wcjd.v11.i11.1782] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Carty E, Rampton DS. Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol 2003;56:351-61. [PMID: 12968979 DOI: 10.1046/j.1365-2125.2003.01965.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
98 Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World J Gastroenterol 2003; 9(10): 2300-2307 [PMID: 14562397 DOI: 10.3748/wjg.v9.i10.2300] [Cited by in CrossRef: 183] [Cited by in F6Publishing: 202] [Article Influence: 9.6] [Reference Citation Analysis]
99 Kämäräinen M, Heiskala K, Knuutila S, Heiskala M, Winqvist O, Andersson LC. RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am J Pathol. 2003;163:11-20. [PMID: 12819006 DOI: 10.1016/s0002-9440(10)63625-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
100 Nikolaus S, Rutgeerts P, Fedorak R, Steinhart AH, Wild GE, Theuer D, Möhrle J, Schreiber S. Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut 2003;52:1286-90. [PMID: 12912859 DOI: 10.1136/gut.52.9.1286] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 3.9] [Reference Citation Analysis]
101 Myles MH, Livingston RS, Livingston BA, Criley JM, Franklin CL. Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect Immun 2003;71:3885-93. [PMID: 12819073 DOI: 10.1128/IAI.71.7.3885-3893.2003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
102 Winkler MF. Treatment of Pouchitis: Is There a Role for Probiotics? Topics in Clinical Nutrition 2003;18:162-9. [DOI: 10.1097/00008486-200307000-00004] [Reference Citation Analysis]
103 Sugiyama Y, Ohni M, Sudoh N, Mizukawa S, Akishita M, Toba K. Recurrent colitis with different causes. J Am Geriatr Soc 2003;51:723-4. [PMID: 12752856 DOI: 10.1034/j.1600-0579.2003.00224.x] [Reference Citation Analysis]
104 James SP. 19. Immunologic, gastroenterologic, and hepatobiliary disorders. J Allergy Clin Immunol 2003;111:S645-58. [PMID: 12592310 DOI: 10.1067/mai.2003.85] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Viscido A, Aratari A, D’ovidio V, Guagnozzi D, Annovazzi A, Caprilli R. The Gastroenterologist’s Update on Inflammatory Bowel Diseases. Nuclear Medicine in the Management of Inflammatory and Infectious Diseases 2003. [DOI: 10.1007/978-3-662-05289-1_1] [Reference Citation Analysis]
106 Muijsers RB, Goa KL. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis. Drugs. 2002;62:1689-1705. [PMID: 12109930 DOI: 10.2165/00003495-200262110-00010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
107 &NA;. Treatment options for ulcerative colitis. Inpharma Weekly 2002;&NA;:10. [DOI: 10.2165/00128413-200213230-00023] [Reference Citation Analysis]